AlphaFold predicted structure
TRAF7 · Q6Q0C0

Mean pLDDT
79.7/ 100
Confident
670 residues
Confidence breakdown
- Very high(≥ 90)51%
- Confident(70–90)29%
- Low(50–70)2%
- Very low(< 50)18%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
TNF receptor associated factor 7
Annotations refreshed 1 month ago.
Diagnostic Grade (Green)
DDG2P
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownFamilial non syndromic congenital heart disease
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownFetal anomalies
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownIntellectual disability
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownRare syndromic craniosynostosis or isolated multisuture synostosis
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedClefting
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedEarly onset or syndromic epilepsy
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownLimb disorders
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknowncardiac, facial, and digital anomalies with developmental delay
TRAF7-associated heart defect-digital anomalies-facial dysmorphism-motor and speech delay syndrome
Global developmental delay
meningioma
Abnormality of limbs
Abnormal digit morphology
Abnormal heart morphology
hereditary disease
peritoneal mesothelioma
craniosynostosis
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
E3 ubiquitin-protein ligase TRAF7
E3 ubiquitin and SUMO-protein ligase that plays a role in different biological processes such as innate immunity, inflammation or apoptosis (PubMed:15001576, PubMed:37086853). Potentiates MAP3K3-mediated activation of JUN/AP1 and DDIT3 transcriptional regulators (PubMed:14743216). Negatively regulates MYB transcriptional activity by sequestering it to the cytosol via SUMOylation (By similarity). Plays a role in the phosphorylation of MAPK1 and/or MAPK3, probably via its interaction with MAP3K3. Negatively regulates RLR-mediated innate immunity by promoting 'Lys-48'-linked ubiquitination of TBK1 through its RING domain to inhibit the cellular antiviral response (PubMed:37086853). Promotes 'Lys-29'-linked polyubiquitination of NEMO/IKBKG and RELA leading to targeting these two proteins to lysosomal degradative pathways, reducing the transcriptional activity of NF-kappa-B (PubMed:21518757)
TRAF7 · Q6Q0C0

Mean pLDDT
79.7/ 100
Confident
670 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0